Jeff Ubben: VRX And AGN A ‘Perfect Match’

One of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) (TSE:VRX)’s top shareholders on Tuesday threw his support behind its proposed takeover bid with a high-profile activist investor for Botox-maker Allergan, Inc. (NYSE:AGN).

“Allergan, Inc. (NYSE:AGN) and Valeant are a perfect match,” said hedge fund manager Jeff Ubben in an interview with CNBC. “We think it’s a really, really powerful combination.”




About the Author

Sheeraz Raza
Sheeraz is our COO (Chief - Operations), his primary duty is curating and editing of ValueWalk. He is main reason behind the rapid growth of the business. Sheeraz previously ran a taxation firm. He is an expert in technology, he has over 5.5 years of design, development and roll-out experience for SEO and SEM. - Email: sraza(at)valuewalk.com